fbpx

Valuation Through A Health Lense & What Professional Investors Look For When Investing

Investor —
19 October
10:00 - 11:00

Webinar

Join us for an overview of health-focused company valuation methods by a seasoned valuation expert, sharing his experience and insights from over 700 health focused company valuations around the globe.

Moderator: Jeremy McCrohan, Norwegian Health Investor Network

(Head of Investor Relations, Norway Health Tech)

Register

Program

See more
19 October
10:00

Introduction & brief overview of the new Norwegian Health Investor Network platform

Jeremy McCrohan
19 October
10:05

Presentation by Patrik Frei (CEO, Venture Valuations)

  • Risk and return – Valuation is a key factor when investing in any life science company.

Learn how to calculate and determine the right assumptions for any biotech, healthtech or medtech company and how to avoid common pitfalls when considering an investment.

Patrick Frei

Venture Valuation AG
19 October
10:50

Q&A from audience

Speakers

Patrick Frei

CEO - Venture Valuation AG
Read more

Jeremy McCrohan

Head of Investor Relations

jeremy.mccrohan@norwayhealthtech.com

Read more

Read also

Investor —

A New Hub for Creating Financial Room to Roam in The Health Industry

In these business-as-unusual-times, the health industry is experiencing a moment of extreme relevance as global leaders call for health technology to battle the pandemic and reduce pressure on the frontlines.

26 June
Read more
Biotech — Investor —

Biovotec AS – Private placement successfully completed

Biovotec announces today that it has raised MNOK 10,0 in a private placement and has secured further funding of an additional MNOK 20,0 conditioned on reaching predefined milestones.

12 October
Read more